RetiSpec Inc. announced today that it is partnering with Gentex Corporation to engineer, manufacture and commercialize technology for the early detection of Alzheimer's disease. By harnessing hyperspectral imagery, RetiSpec's patented technology allows for the rapid, simple and cost-effective identification of Alzheimer's biomarkers years before the emergence of clinical symptoms.